HYDERABAD, India – If it can overcome some significant hurdles, India could emerge as a major developer of biosimilars in the coming years, said industry players speaking at the largest annual meeting of biotech companies here. Read More

Scientists from Taiwan National University have shown that the reason that hepatitis B is typically cleared in adults, but becomes chronic when individuals are first infected as children, is related to the development of the gut microbiome. A string B-cell and T-cell immune response is necessary to clear hepatitis B infection, and the authors showed that in young mice, that immune response was dependent on the maturation of the gut microbiome. Read More

HYDERABAD, India – India may have a proven track record developing generics, but it is limping far behind other countries in the discovery and development of new drugs, areas which call for entirely new skill sets and investments. Read More

SHANGHAI – Glaxosmithkline plc, of London, has firmly denied rumors of sizable layoffs in its troubled China operation, reasserting its commitment to the country. While the company is sticking to its story that nobody will be let go, the firm also said in a statement it will continue to "realign resources to build a highly efficient and sustainable business." Read More

HONG KONG — Japanese researchers have for the first time successfully induced human embryonic stem cells to self-organize into a functional three-dimensional structure similar to the cerebellum, providing clues on how to recreate neural structures in the laboratory and potentially leading to new drug discoveries. Read More